Example: stock market
DRUG NAME: Rituximab - BC Cancer
dyspnea, rhinitis, vomiting, and flushing. Symptoms may progress in severity and include acute respiratory distress syndrome and angioedema. Severe, potentially fatal, infusion-related reactions (0.04-0.07%) may occur within 24 hours of the first infusion, and may be clinically indistinguishable from anaphylactic reactions.
Download DRUG NAME: Rituximab - BC Cancer
15
Information
Domain:
Source:
Link to this page: